I‐Chen Wu

2.4k total citations
99 papers, 1.8k citations indexed

About

I‐Chen Wu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, I‐Chen Wu has authored 99 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Surgery, 30 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in I‐Chen Wu's work include Esophageal Cancer Research and Treatment (41 papers), Helicobacter pylori-related gastroenterology studies (28 papers) and Esophageal and GI Pathology (16 papers). I‐Chen Wu is often cited by papers focused on Esophageal Cancer Research and Treatment (41 papers), Helicobacter pylori-related gastroenterology studies (28 papers) and Esophageal and GI Pathology (16 papers). I‐Chen Wu collaborates with scholars based in Taiwan, United States and India. I‐Chen Wu's co-authors include Deng‐Chyang Wu, Ming‐Tsang Wu, Fang‐Jung Yu, Shah‐Hwa Chou, Fu‐Chen Kuo, Chien‐Yu Lu, Yao‐Kuang Wang, Jang‐Ming Lee, Hsiang‐Chen Wang and Jaw‐Yuan Wang and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

I‐Chen Wu

95 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I‐Chen Wu Taiwan 25 976 502 318 311 259 99 1.8k
Hyun Joo Jang South Korea 25 847 0.9× 630 1.3× 385 1.2× 288 0.9× 456 1.8× 120 1.8k
Hiromichi Maeda Japan 24 882 0.9× 584 1.2× 794 2.5× 257 0.8× 145 0.6× 196 2.1k
Rajiv Kumar India 17 255 0.3× 267 0.5× 340 1.1× 253 0.8× 156 0.6× 75 1.1k
Bich Nguyen Canada 22 680 0.7× 364 0.7× 217 0.7× 247 0.8× 120 0.5× 98 2.0k
Tatsuo Kanda Japan 26 1.9k 2.0× 1.7k 3.5× 535 1.7× 327 1.1× 662 2.6× 105 2.8k
Marino Venerito Germany 23 1.1k 1.1× 622 1.2× 321 1.0× 279 0.9× 421 1.6× 100 1.8k
Koen J. Hartemink Netherlands 25 478 0.5× 1.1k 2.3× 786 2.5× 245 0.8× 58 0.2× 98 2.6k
Ryoji Fukushima Japan 24 699 0.7× 756 1.5× 611 1.9× 316 1.0× 239 0.9× 59 2.0k
Lars‐Erik Hansson Sweden 30 2.4k 2.5× 1.5k 3.0× 811 2.6× 539 1.7× 441 1.7× 48 3.8k
René Baumann France 26 485 0.5× 444 0.9× 268 0.8× 225 0.7× 69 0.3× 90 2.2k

Countries citing papers authored by I‐Chen Wu

Since Specialization
Citations

This map shows the geographic impact of I‐Chen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Chen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Chen Wu more than expected).

Fields of papers citing papers by I‐Chen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Chen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Chen Wu. The network helps show where I‐Chen Wu may publish in the future.

Co-authorship network of co-authors of I‐Chen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Chen Wu. A scholar is included among the top collaborators of I‐Chen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Chen Wu. I‐Chen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jeong, Sohyun, Yao‐Kuang Wang, I‐Chen Wu, et al.. (2024). Microbiome signatures associated with clinical stages of gastric Cancer: whole metagenome shotgun sequencing study. BMC Microbiology. 24(1). 139–139. 5 indexed citations
3.
Hsieh, Hui‐Min, Yi‐Hsun Chen, Wen‐Hung Hsu, et al.. (2024). Cost‐effectiveness of universal esophageal cancer screening for newly diagnosed oral cancer patients. Journal of Gastroenterology and Hepatology. 39(12). 2778–2786. 1 indexed citations
4.
Wang, Yao‐Kuang, Yao‐Hsiang Shih, Yin‐Yi Chu, et al.. (2022). Substance use and esophageal neuroendocrine neoplasm: A case–control study. The Kaohsiung Journal of Medical Sciences. 38(12). 1224–1229. 1 indexed citations
5.
Hsieh, Meng‐Shu, Fu‐Chen Kuo, Meng‐Chieh Wu, et al.. (2021). Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial. Journal of the Formosan Medical Association. 121(8). 1450–1457. 9 indexed citations
6.
7.
Chen, Yi‐Hsun, Yao‐Kuang Wang, Yun‐Shiuan Chuang, et al.. (2020). Endoscopic Surveillance for Metachronous Esophageal Squamous Cell Neoplasms among Head and Neck Cancer Patients. Cancers. 12(12). 3832–3832. 15 indexed citations
8.
Chuang, Yun‐Shiuan, Meng‐Chieh Wu, Yao‐Kuang Wang, et al.. (2019). Risks of substance uses, alcohol flush response, Helicobacter pylori infection and upper digestive tract diseases—An endoscopy cross‐sectional study. The Kaohsiung Journal of Medical Sciences. 35(6). 341–349. 4 indexed citations
9.
Wu, Meng‐Chieh, Yao‐Kuang Wang, Chung‐Jung Liu, et al.. (2017). Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori. Gastroenterology Research and Practice. 2017. 1–6. 9 indexed citations
10.
Wang, Yao‐Kuang, Yun‐Shiuan Chuang, Ka‐Wo Lee, et al.. (2017). Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes. International Journal of Cancer. 141(10). 1987–1996. 41 indexed citations
11.
Wu, I‐Chen, Yao‐Hsiang Shih, Meng‐Chieh Wu, et al.. (2015). Comparison of Second-Line Quadruple Therapies with or without Bismuth forHelicobacter pyloriInfection. BioMed Research International. 2015. 1–6. 19 indexed citations
12.
13.
Wu, I‐Chen, et al.. (2015). A long‐term risk‐benefit analysis of low‐dose aspirin in primary prevention. European Journal of Clinical Investigation. 46(2). 130–140. 2 indexed citations
14.
Huang, Shih‐Hui, I‐Chen Wu, Deng‐Chyang Wu, et al.. (2012). Occupational risks of esophageal cancer in Taiwanese men. The Kaohsiung Journal of Medical Sciences. 28(12). 654–659. 13 indexed citations
15.
Yen, Li-Chen, Yih‐Huei Uen, Deng‐Chyang Wu, et al.. (2010). Activating KRAS Mutations and Overexpression of Epidermal Growth Factor Receptor as Independent Predictors in Metastatic Colorectal Cancer Patients Treated With Cetuximab. Annals of Surgery. 251(2). 254–260. 77 indexed citations
16.
Wu, I‐Chen, Sheau‐Fang Yang, Chun‐Chieh Wu, et al.. (2010). Expression of Osteopontin Protein in Esophageal Squamous Cell Carcinoma. 21(6). 419–426. 1 indexed citations
17.
Wu, Meng‐Chieh, I‐Chen Wu, Jeng‐Yih Wu, Deng-Chyang Wu, & Wen‐Ming Wang. (2009). Superior mesenteric artery syndrome in a diabetic patientwith acute weight loss. World Journal of Gastroenterology. 15(47). 6004–6004. 15 indexed citations
18.
Tsai, Hsiang‐Lin, Chien-Yu Lu, Deng‐Chyang Wu, et al.. (2009). Significant Correlation between Polymorphisms of UGT1A1 Gene and Low Irinotecan Toxicity in Colorectal Cancer Patients with FOLFIRI. 2(1). 21–26. 4 indexed citations
19.
Hu, Hong‐Ming, Fu‐Chen Kuo, Pin‐I Hsu, et al.. (2009). Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. Journal of Antimicrobial Chemotherapy. 63(5). 1017–1024. 79 indexed citations
20.
Hsu, Wen‐Hung, et al.. (2009). Colon Schwannoma:A Case Report. 20(3). 255–259. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyun Joo Jang Breakdown of academic impact, for papers by Hiromichi Maeda Breakdown of academic impact, for papers by Rajiv Kumar Breakdown of academic impact, for papers by Bich Nguyen Breakdown of academic impact, for papers by Tatsuo Kanda Breakdown of academic impact, for papers by Marino Venerito Breakdown of academic impact, for papers by Koen J. Hartemink Breakdown of academic impact, for papers by Ryoji Fukushima Breakdown of academic impact, for papers by Lars‐Erik Hansson Breakdown of academic impact, for papers by René Baumann
Rankless by CCL
2026